SECTION I · THE BRIEF
Brief #77216Updated 11 MAR 2026SAN DIEGO, CALeverMEDICAL ORGANIZATIONS
Employbl Dossier

Medical Director, Autoimmunity

Fate Therapeutics, Inc. provides biotechnology services. The Company researches and develops therapies to repair and regenerate body tissues with the help of stem cells. Fate Therapeutics conducts business in the United…

Location
San Diego, CA
Company size
181–181
Posted
3mo ago
Via
Lever
Section II — RestrictedMembers only
  • Comp band & equity package
  • Seniority & experience requirements
  • Interview process & rubric
  • Hiring manager & team context
  • Growth trajectory in this role
  • Offer & decision timeline

7-day free trial · $25/mo · cancel anytime

Fate Therapeutics logo

Medical Director, Autoimmunity - Fate Therapeutics

View Company Profile
Job Title
Medical Director, Autoimmunity
Job Location
San Diego, CA
Job Description
Responsibilities
  • Provide clinical leadership of a comprehensive and integrated Clinical Development Plan for individual autoimmune programs from first-in-human studies through registrational studies.
  • Contribute to study designs, lead protocol development, and collaborate with cross-functional teams in study start-up activities in partnership with clinical investigators, key opinion leaders and Health Authorities.
  • Direct hands-on involvement in all aspects of study conduct, in collaboration with Fate clinical development and contracted personnel, in the conduct of clinical activities including medical monitoring, data review, analysis, and reporting that conforms to the highest ethical, safety and quality standards and in compliance with Fate, GCP and regulatory standards.
  • Remain current on the therapeutic landscape in the relevant therapeutic areas through review of the scientific literature, interactions with key opinion leaders and other external experts and attendance at relevant scientific meetings to provide input and guidance for the strategic direction of Fate programs.
  • May participate as clinical contributor in Fate business development and investor-related activities.
  • May participate in Health Authority interactions.
  • Review available preclinical data that could inform the design of future clinical trials.
  • Attend and present at investigator meetings and site initiation visits as applicable.
  • Actively engage in the preparation of Clinical Study Reports, Annual Reports and other safety reports, Health Authority pre-meeting packages, Investigator Brochures, and other periodic clinical reports.
  • Collaborating with cross-functional groups formulate publication strategy including active participation in authoring, preparation and review of manuscripts, conference abstracts and presentations and other external presentations of clinical data.
  • May oversee direct reports or contractors.
  • Qualifications
  • M.D., M.D./Ph.D. degree or equivalent.
  • Board Certification or Board Eligibility in the field of medical rheumatology preferred.
  • 4+ years of experience in clinical development, including the design and execution of clinical trials, preferably within a pharmaceutical, biotech or CRO.
  • Experience in managing clinical programs from Phase 1 through Phase 3 is preferred.
  • Knowledge of autoimmune diseases such as lupus, systemic sclerosis, vasculitis, rheumatoid arthritis, or other relevant indications.
  • Experience or exposure to the development of adoptive cell therapies or biologic therapies is desirable.
  • Experience with U.S. and European Health Authority interactions and submission of clinical regulatory documents is desirable.
  • Willingness to engage with investigators, key opinion leaders, and external advisors, as well as effectively give presentations at conferences, advisory meetings, and other public forums.
  • Ability to multi-task and willingness to flexibly contribute simultaneously to multiple facets of drug development; willingness to learn new therapeutic areas.
  • Willingness to educate and mentor internal and external colleagues and collaborators.

  • Working Conditions & Physical Requirements
  • Travel will be required (up to 30%).
  • Subject to extended periods of sitting and standing, vision to monitor, and moderate noise levels.
  • Compensation
  • The salary offer will be based on a variety of factors, including level, experience, qualifications, internal equity, and location.
  • Fate offers a competitive employment package that includes an annual bonus, equity, and a generous benefits package.
  • The anticipated salary range for this role is $290,000 - $310,000.
  • Get the Saturday tech briefing

    New company profiles, funding moves, and who’s hiring across the market — every Saturday morning.

    Fate Therapeutics Headquarters Location

    San Diego, CA

    View company profile

    Fate Therapeutics Company Size

    Between 181 - 181 employees

    Fate Therapeutics Founded Year

    2007

    Fate Therapeutics Total Amount Raised

    $1,348,828,288

    Fate Therapeutics Funding Rounds

    View funding details
    • Grant

      $7,900,000 USD

    • Grant

      $7,900,000 USD

    • Post Ipo Equity

      $100,000,000 USD

    • Post Ipo Equity

      $100,000,000 USD

    • Post Ipo Equity

      $432,000,000 USD

    • Post Ipo Equity

      $432,000,000 USD

    • Post Ipo Equity

      $201,300,000 USD

    • Post Ipo Equity

      $201,300,000 USD

    • Post Ipo Equity

      $173,000,000 USD

    • Post Ipo Equity

      $173,000,000 USD

    • Post Ipo Equity

      $172,500,000 USD

    • Post Ipo Equity

      $172,500,000 USD

    • Grant

      $4,000,000 USD

    • Grant

      $4,000,000 USD

    • Post Ipo Equity

      $42,900,000 USD

    • Post Ipo Equity

      $42,900,000 USD

    • Post Ipo Equity

      $56,749,988 USD

    • Post Ipo Equity

      $56,749,988 USD

    • Post Ipo Equity

      $10,290,000 USD

    • Post Ipo Equity

      $10,290,000 USD

    • Post Ipo Equity

      $32,000,000 USD

    • Post Ipo Equity

      $32,000,000 USD

    • Post Ipo Equity

      $8,000,000 USD

    • Post Ipo Equity

      $8,000,000 USD

    • Post Ipo Debt

      $20,000,000 USD

    • Post Ipo Debt

      $20,000,000 USD

    • IPO

      $0

    • Series Unknown

      $9,200,000 USD

    • Series Unknown

      $9,200,000 USD

    • Series B

      $35,988,360 USD

    • Series B

      $35,988,360 USD

    • Debt Financing

      $1,000,000 USD

    • Debt Financing

      $1,000,000 USD

    • Series B

      $30,000,000 USD

    • Series B

      $30,000,000 USD

    • Series A

      $12,000,000 USD

    • Series A

      $12,000,000 USD